Key statistics
On Friday, MaxCyte Inc (MXCT:NSQ) closed at 4.10, -26.06% below its 52-week high of 5.55, set on Jan 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.29 |
---|---|
High | 4.29 |
Low | 4.04 |
Bid | 3.71 |
Offer | 4.41 |
Previous close | 4.35 |
Average volume | 366.27k |
---|---|
Shares outstanding | 105.17m |
Free float | 98.51m |
P/E (TTM) | -- |
Market cap | 431.20m USD |
EPS (TTM) | -0.3408 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Holding(s) in Company
- TR-1: Notification of major holdings
- Signing of Strategic Platform License
- MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases
- Exercise of options and PDMR dealing
- Bioprocessing Conference Participation
- MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference
- Total Voting Rights
- Exercise of options and PDMR dealing
- Filing of Form 10-Q
More ▼